We are live on ! Find out more
GNOM icon

Global X Genomics & Biotechnology ETF
GNOM

54 hedge funds and large institutions have $121M invested in Global X Genomics & Biotechnology ETF in 2021 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 18 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

350% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 4

220% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 5

37% more capital invested

Capital invested by funds: $88.3M → $121M (+$33M)

20% more funds holding

Funds holding: 45 → 54 (+9)

2.23% more ownership

Funds ownership: 8.82% → 11.05% (+2.2%)

Holders
54
Holders Change
+9
Holders Change %
+20%
% of All Funds
0.95%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
18
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Mirae Asset Global Investments
Mirae Asset Global Investments
South Korea
+$21.3M
2
PAG
Private Advisor Group
New Jersey
+$8.98M
3
CW
CreativeOne Wealth
Kansas
+$5.01M
4
SFS
Sowell Financial Services
Arkansas
+$1.98M
5
MIG
McGuire Investment Group
Rhode Island
+$1.78M

Top Sellers

Rank Fund Capital Flow
1
T
TRUADVICE
Florida
-$3.65M
2
FTUS
Flow Traders U.S.
New York
-$1.05M
3
SPC
Sigma Planning Corp
Michigan
-$455K
4
PWM
PRW Wealth Management
Massachusetts
-$230K
5
Barclays
Barclays
United Kingdom
-$100K
Name Holding Trade Value Shares
Change 		Change in
Stake
Financial Engines Advisors
26
Financial Engines Advisors
California
$255K +$270K +2,884 New
Optiver Holding
27
Optiver Holding
Netherlands
$239K +$169K +1,802 +205%
BJL
28
Brighton Jones LLC
Washington
$238K -$4.12K -44 -2%
HSBC Holdings
29
HSBC Holdings
United Kingdom
$223K – – –
Commonwealth Equity Services
30
Commonwealth Equity Services
Massachusetts
$213K +$226K +2,407 New
RJA
31
Raymond James & Associates
Florida
$213K +$226K +2,409 New
Rockefeller Capital Management
32
Rockefeller Capital Management
New York
$208K -$3.84K -41 -2%
CFGS
33
Concourse Financial Group Securities
Alabama
$208K +$656 +7 +0.3%
CA
34
Cetera Advisors
Colorado
$204K +$215K +2,300 New
PG
35
Patten Group
Tennessee
$202K -$3.19K -34 -1%
EDRH
36
Edmond de Rothschild Holding
Switzerland
$183K +$29.5K +315 +18%
Vontobel Holding
37
Vontobel Holding
Switzerland
$173K +$14.1K +150 +8%
Osaic Holdings
38
Osaic Holdings
Arizona
$162K +$72.5K +774 +72%
CF
39
Centaurus Financial
California
$114K +$120K +1,282 New
JCM
40
Jacobi Capital Management
Pennsylvania
$92K – – –
FFA
41
Founders Financial Alliance
North Carolina
$83K – – –
HI
42
Harbour Investments
Wisconsin
$79K – – –
IA
43
IFP Advisors
Florida
$78K +$60K +640 +269%
APA
44
American Portfolios Advisors
New York
$60K – – –
BW
45
Bison Wealth
Georgia
$51K – – –
FDCDDQ
46
Federation des caisses Desjardins du Quebec
Quebec, Canada
$23.2K – – –
BFEC
47
Benjamin F. Edwards & Company
Missouri
$20K – – –
Simplex Trading
48
Simplex Trading
Illinois
$12K – – –
GKWIM
49
Gerber Kawasaki Wealth & Investment Management
California
$11K +$12.2K +130 New
MIM
50
Macroview Investment Management
Maryland
$8K – – –
1
2
3

GNOM Hedge Fund Activity: Q3 2021 in Review

54 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Global X Genomics & Biotechnology ETF (GNOM) for Q3 2021, worth a combined $121M — up 37% from $88.3M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new GNOM positions and 5 closed out — a net gain of 11 holders — while 18 added to existing stakes and 4 trimmed.

The largest buyer was Mirae Asset Global Investments, adding an estimated $21.3M. The largest seller was TRUADVICE, exiting entirely with an estimated $3.65M sold.

  • 54 institutional investors held Global X Genomics & Biotechnology ETF (GNOM) as of Q3 2021, up from 45 in Q2 2021.
  • Funds reported $121M of Global X Genomics & Biotechnology ETF stock for Q3 2021, up 37% quarter-over-quarter.
  • 16 funds opened new Global X Genomics & Biotechnology ETF positions in Q3 2021 and 5 closed out, a net change of +11 holders.
  • The largest Global X Genomics & Biotechnology ETF buyer in Q3 2021 was Mirae Asset Global Investments, an estimated $21.3M added.
  • The largest Global X Genomics & Biotechnology ETF seller in Q3 2021 was TRUADVICE, an estimated $3.65M sold.

Based on aggregated 13F filings for Q3 2021.